TUNGKOL SA EPISODE NA ITO
Featuring a slide presentation and related discussion from Dr Saad Zafar Usmani, including the following topics:
- Evolution of therapeutic decision-making for patients with newly diagnosed multiple myeloma (MM) (0:00)
- Quadruplet therapy for transplant-eligible patients with newly diagnosed MM (6:26)
- Daratumumab with lenalidomide as maintenance therapy after transplant in newly diagnosed MM (16:16)
- Therapeutic options for transplant-ineligible patients with MM (19:51)
Ingles
Estados Unidos
KOPYA NG SALIN 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
I-SEARCH ANG MGA NAKARAANG EPISODE
I-search ang mga nakaraang episode ng Research To Practice | Oncology Videos.
IBA PANG MGA EPISOD SA PODCAST NA ITO
Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics:
Introduction and Overview of Bispecific Antibodies in the Clinic (0:00)
Current a…
Featuring perspectives from Prof Susana Banerjee, including the following topics:
Overview of the biology and treatment of low-grade serous ovarian cancer (0:00)
Mechanism of action of avutometinib/defactinib (10:16)
RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian…
Featuring a slide presentation from Dr Julia Rotow, including the following topics:
Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00)
Key findings from the Phase III…
Featuring perspectives from Dr Catherine C Coombs, including the following topics:
Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (0:00)
Role…
Featuring perspectives from Dr Catherine C Coombs, including the following topics:
Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00)
Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor …
Paunawa: Ang podcast at artwork na naka-embed sa page na ito ay mula sa Dr Neil Love, na pag-aari ng may-ari nito at hindi kaakibat o ineendorso ng Listen Notes, Inc.
I-EDIT
Salamat sa pagtulong na mapanatiling naka-update ang database ng podcast.
